Catalyst

Slingshot members are tracking this event:

Phase 2 data of TRC105 for Renal Cell Carcinoma due June 2018

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
TCON Community voting in process

Additional Information

Additional Relevant Details Initially expected late 2016, it is now due for June 2018.
https://www.clinical...
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 2 Data, Trc105, Renal Cell Carcinoma